<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03295487</url>
  </required_header>
  <id_info>
    <org_study_id>Saramohamed7880</org_study_id>
    <nct_id>NCT03295487</nct_id>
  </id_info>
  <brief_title>ToT and Estrogen in Postmenopausal Females</brief_title>
  <official_title>The Value of Local Estrogen After TVT_O anti_incontinence Surgery in Postmenopausal Females.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kasr El Aini Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kasr El Aini Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the subjective and objective outcomes of TVT-O procedure alone versus the same
      procedure followed by the use of premarin vaginal cream for 3 months in postmenopausal female
      with genuine stress incontinence.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      a randomized controlled trial comparing the effect of using local estrogen cream after tot in
      postmenopausal female
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2017</start_date>
  <completion_date type="Anticipated">September 30, 2017</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2017</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>outcome of the surgery</measure>
    <time_frame>immediately after surgery</time_frame>
    <description>clinical and urodynamic test improvment of the stress incontinence</description>
  </primary_outcome>
  <primary_outcome>
    <measure>outcome of the surgery</measure>
    <time_frame>3 months after surgery</time_frame>
    <description>clinical and urodynamic test improvment of the stress incontinence</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>nocturia ,</measure>
    <time_frame>immediatly after surgery</time_frame>
    <description>symptom and sign from the patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>frequency,</measure>
    <time_frame>immediatly after surgery</time_frame>
    <description>symptom and sign from the patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>denovo urgency</measure>
    <time_frame>immediatly after surgery</time_frame>
    <description>symptom and sign from the patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>denovo urgency</measure>
    <time_frame>3 months after surgery</time_frame>
    <description>symptom and sign from the patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>nocturia</measure>
    <time_frame>3 months after surgery</time_frame>
    <description>symptom and sign from the patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>frequency</measure>
    <time_frame>3 months after surgery</time_frame>
    <description>symptom and sign from the patients</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Stress Urinary Incontinence</condition>
  <condition>Postmenopausal Disorder</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>post menopausal female with genuine stress incontinence treated by TVT-O and local estrogen cream for 3 months after surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>post menopausal female with genuine stress incontinence treated by TVT-O only</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>TVT-O</intervention_name>
    <description>transobturator tape has been applied to all the patients in the study,and local estrogen vaginal cream is only applied to patients in group A</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
    <other_name>local vaginal estrogen cream</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        -menopause patients included in group A should have: no history of breast cancer, ovarian
        cancer or uterine cancer No history of blood clots or thromboembolism No history of heart
        disease or stroke No history liver disease. Endometrial thickness less than 5mm Have a
        normal mammogram

        Exclusion Criteria:

          -  presence of urge or mixed incontinence .
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>49 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kasr El Ainiy Hospital</name>
      <address>
        <city>Cairo</city>
        <zip>11562</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>sarah M Hassan, Lecturer</last_name>
      <phone>01003733671</phone>
      <email>saramohamed7880@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 20, 2017</study_first_submitted>
  <study_first_submitted_qc>September 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 28, 2017</study_first_posted>
  <last_update_submitted>September 22, 2017</last_update_submitted>
  <last_update_submitted_qc>September 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kasr El Aini Hospital</investigator_affiliation>
    <investigator_full_name>sarah mohamed hassan</investigator_full_name>
    <investigator_title>lecturer of obstetrics and gynecology</investigator_title>
  </responsible_party>
  <keyword>post menopausal stress incontinence</keyword>
  <keyword>local estrogen</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
    <mesh_term>Urinary Incontinence, Stress</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Estrogens</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

